Reset filter
Keywords
Clinical Trial ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
    1. 7.1. Anesthesiology
    1. 7.2. Dermatology
    1. 7.3. ENT
    1. 7.4. Geriatrics
    1. 7.5. Gynecology/Obstetrics
    1. 7.6. Internal Medicine
      1. Hematology
      1. Infectious Diseases
      1. Cardiology/Angiology
      1. Pneumology
      1. Gastroenterology
      1. Nephrology
      1. Endocrinology/Metabolic Diseases
      1. Rheumatology
    1. 7.7. Neurology
    1. 7.8. Ophthalmology
    1. 7.9. Palliative Care
    1. 7.10. Pathology/Forensics
    1. 7.11. Pediatrics
    1. 7.12. Psychiatry/Psychosomatics
    1. 7.13. Radiology
    1. 7.14. Surgery
      1. General/Visceral Surgery
      1. Neurosurgery
      1. Plastic Surgery
      1. Thoracic Surgery
      1. Trauma/Orthopedics
      1. Vascular Surgery
    1. 7.15. Urology
    1. 7.16. Dental Medicine/OMS
Selected data models

You must log in to select data models for download or further analysis.

152 Search results.
Relevance Rating New first Old first

NCT01302834 Quality of Life - RTOG 1016 QN: Radiation Therapy Oncology Group Phase III Head and Neck Cancer Hearing Handicap Inventory for Adults (HHIA-S) - 3183758v1.0 - RTOG 1016 QN: Radiation Therapy Oncology Group Phase III Head and Neck Cancer Hearing Handicap Inventory for Adults (HHIA-S)

- 1/9/15 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Header Module, HEARING HANDICAP INVENTORY FOR ADULTS SCREENING QUESTIONNAIRE (NEWMAENT AL., 1990; NEWMAENT AL., 1991)
RTOG 1016 QN: Radiation Therapy Oncology Group Phase III Head and Neck Cancer Hearing Handicap Inventory for Adults (HHIA-S) Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9A132BA5-9085-FFE2-E040-BB89AD43727A

Eligibility DRKS00005561 NCT00508664 Squamous Cell Carcinoma of the Hypopharynx - Eligibility

- 9/20/21 - 1 form, 2 itemgroups, 31 items, 2 languages
Itemgroups: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00508664

Eligibility Head and Neck Cancer NCT02124707

- 2/2/20 - 1 form, 2 itemgroups, 13 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Weekly Carboplatin, Paclitaxel and Cetuximab Treatment for Patients With Recurrent or Metastatic SCCHN; ODM derived from: https://clinicaltrials.gov/show/NCT02124707

Eligibility Head and Neck Cancer NCT00670397

- 2/2/20 - 1 form, 1 itemgroup, 19 items, 1 language
Itemgroup: Criteria
Photodynamic Therapy Using HPPH in Treating Patients With Recurrent Dysplasia, Carcinoma in Situ, or Stage I Oral Cavity Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00670397

Eligibility Head and Neck Cancer NCT02442739

- 4/2/19 - 1 form, 2 itemgroups, 22 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Safety Study of Ketamine for Preventing Depression in Patients Undergoing Treatment for Head and Neck Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02442739

Eligibility Head and Neck Cancer NCT02410382

- 4/1/19 - 1 form, 2 itemgroups, 16 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Dexamethasone for Treatment of Radiation-related Fatigue in Patients Receiving RT for Head-neck and Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02410382

Eligibility Recurrent Head and Neck Cancer NCT02289209

- 6/27/19 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Reirradiation With MK-3475 in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck; ODM derived from: https://clinicaltrials.gov/show/NCT02289209

Eligibility Papillary Thyroid Cancer NCT01974284

- 6/5/19 - 1 form, 2 itemgroups, 14 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01974284

Eligibility Low-risk Papillary Thyroid Cancer NCT02408887

- 4/29/19 - 1 form, 2 itemgroups, 17 items, 1 language
Itemgroups: Criteria, Exclusion Criteria
Total Thyroidectomy With and Without Prophylactic Central Neck Lymph Node Dissection in People With Low-risk Papillary Thyroid Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02408887

Eligibility Carcinoma NCT00243347

- 1/25/17 - 1 form, 2 itemgroups, 13 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00243347

Eligibility Head and Neck Squamous Carcinoma NCT00634595

- 9/17/21 - 1 form, 2 itemgroups, 13 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Trial of E10A in Head and Neck Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00634595

Head and Neck Cancer NCT00265941 Follow-Up - Follow-up Head and Neck Cancer RTOG-0522 F1 NCT00265941

- 2/5/19 - 1 form, 8 itemgroups, 66 items, 1 language
Itemgroups: Header, CURRENT DISEASE STATUS AND METHOD OF DETERMINATION, DISEASE EVENTS, New primary cancer, Non-Protocol Therapy, Swallowing and Tube Feeding, Protocol Specific Adverse Event Evaluation, Other Adverse Events
RTOG-0522 F1: Follow-up Form Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer NCT00265941 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F65D686D-87BE-6280-E034-0003BA3F9857

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial